IRONWOOD PHARMACEUTICALS, INC. Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity of $301.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-13.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity · last filed 2020-02-13
- IRONWOOD PHARMACEUTICALS, INC. share-based goods and nonemployee services transaction, stockholders' equity for fiscal 2017 was $301.00K, a 43.10% decline from fiscal 2016.
- IRONWOOD PHARMACEUTICALS, INC. share-based goods and nonemployee services transaction, stockholders' equity for fiscal 2016 was $529.00K.
- IRONWOOD PHARMACEUTICALS, INC. share-based goods and nonemployee services transaction, stockholders' equity for fiscal 2014 was $2.62M, a 862.50% increase from fiscal 2013.
- IRONWOOD PHARMACEUTICALS, INC. share-based goods and nonemployee services transaction, stockholders' equity for fiscal 2013 was $272.00K, a 353.33% increase from fiscal 2012.
| Period end | Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity 12 month |
|---|---|
| 2017-12-31 | $301.00K 10-K · filed 2020-02-13 |
| 2016-12-31 | $529.00K 10-K · filed 2019-02-25 |
| 2014-12-31 | $2.62M 10-K · filed 2017-02-22 |
| 2013-12-31 | $272.00K 10-K · filed 2016-02-19 |
| 2012-12-31 | $60.00K 10-K · filed 2015-02-18 |
| 2011-12-31 | $152.00K 10-K · filed 2014-02-07 |
| 2010-12-31 | $123.00K 10-K · filed 2013-02-21 |
| 2009-12-31 | $301.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |